VasDeBlock medical ApS: Financial statements 2023
CVR: 37525758
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
VasDeBlock medical ApS (CVR 37525758) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 60,000 and a net result of DKK -56,179 compared with DKK -112,464 the year before. The profit margin was -93.6%. Equity in the 2023 report amounted to DKK 70,259. The solvency ratio was 77%.
- Revenue
- DKK 60,000
- Gross Profit
- DKK -56,200
- Profit/Loss
- DKK -56,179
- Equity
- DKK 70,259
- Total Assets
- DKK 91,242
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 60K | -56K | -56K | 70K | - |
| 2022 | 0 | -97K | -112K | 32K | - |
| 2021 | 0 | -68K | -83K | 51K | - |
| 2020 | 0 | -247K | -263K | 74K | - |
| 2019 | 17K | -33K | -48K | 70K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
VasDeBlock medical ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -112,464.
About VasDeBlock medical ApS
VasDeBlock medical ApS is a Danish company of the type Anpartsselskab based in Karise, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mette Mikkelsen. The board consists of Nickolei Henrik Nagel (chair), Anders Brummerstedt-Madsen, Henrik Harboe and Niels Bøggild Lindeburg. The company's owners include Mette Mikkelsen, Nickolei Henrik Nagel and HOLDINGSELSKABET TEG AF 2011 ApS. In 2025, the company reported a gross profit of DKK -103,154 and a net result of DKK -103,099 compared with DKK -76,186 the year before. Equity in the 2025 report amounted to DKK 79,417.